SEATTLE, WA—Light Line Medical, which has developed a proprietary method of delivering light to prevent and treat catheter-associated infections, was recognized as one of the top three ‘Most Valued Company’ at the Keiretsu Forum Investor Capital Expo that is showcasing 36 late-stage growth companies seeking funding.
Nearly 50 angel groups, investors from 100+ Family Offices, corporate partners, and hundreds of accredited investors have attended the first two sessions of the Expo. Continue Reading.